MDGL R&D Expenses
Madrigal Pharmaceuticals Inc · R&D Expenses
MDGL R&D Expenses
Latest reported$490.14Mperiod ending
MDGL TTM R&D Expenses ($16.22M → $490.14M)
TTM R&D Expenses
High-resolution chart · PNG
MDGL r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 490,142,000 | |
| 453,045,000 | |
| 388,525,000 | |
| 297,905,000 | |
| 192,643,000 | |
| 209,653,000 | |
| 236,718,000 | |
| 281,710,000 | |
| 283,919,000 | |
| 281,433,000 | |
| 272,350,000 | |
| 272,452,000 | |
| 269,772,000 | |
| 259,666,000 | |
| 245,441,000 | |
| 227,588,000 | |
| 214,190,000 | |
| 207,323,000 | |
| 205,164,000 | |
| 205,704,000 | |
| 204,123,000 | |
| 197,179,000 | |
| 184,809,000 | |
| 156,290,000 | |
| 122,445,000 | |
| 93,351,000 | |
| 72,324,000 | |
| 56,285,000 | |
| 43,049,000 | |
| 32,564,000 | |
| 25,389,000 | |
| 23,030,000 | |
| 23,501,000 | |
| 25,208,000 | |
| 24,390,000 | |
| 23,402,000 | |
| 24,525,000 | |
| 17,606,000 | |
| 16,633,000 | |
| 18,355,000 | |
| 24,963,000 | |
| 41,443,000 | |
| 54,218,000 | |
| 62,625,000 | |
| 64,420,000 | |
| 66,804,000 | |
| 68,205,000 | |
| 72,533,000 | |
| 73,948,000 | |
| 73,063,000 | |
| 71,860,000 | |
| 66,230,000 | |
| 60,350,000 | |
| 53,726,000 | |
| 49,412,000 | |
| 45,920,000 | |
| 44,928,000 | |
| 44,093,000 | |
| 41,463,000 | |
| 39,950,000 | |
| 40,222,000 | |
| 39,493,000 | |
| 40,252,000 | |
| 40,139,000 | |
| 38,200,000 | |
| 38,610,000 | |
| 51,054,000 | |
| 64,852,000 | |
| 79,826,000 | |
| 88,070,000 | |
| 81,581,000 | |
| 71,884,000 | |
| 59,368,000 | |
| 54,639,000 | |
| 52,887,000 | |
| 50,081,000 | |
| 51,864,000 | |
| 38,251,000 | |
| 23,853,000 | |
| 13,325,000 | |
| 0 | |
| 0 | |
| 16,218,000 | |
| 21,843,000 |